Online ECHO Clinic | October 7, 2020

Presentation Titles: What Does a Phase III Vaccine Trial Mean | Clinical Updates

In this session, Dr. Scott McClelland, Professor of Medicine, Epidemiology, and Global Health at the University of Washington, reviews how vaccine trials are conducted, and explains Phase III vaccine trials.  Then, Dr. Jorge Mera, Director of Infectious Diseases for Cherokee Nation Health Services, and Whitney Essex, Family Nurse Practitioner at Cherokee Nation Health Services, share clinical updates on COVID-19 and answer previously submitted questions.

Video

Presenter Bios

Scott McClelland, MD, MPH, is a Professor of Medicine, Epidemiology, and Global Health at the University of Washington.

Jorge Mera, MD, FACP, is the Director of Infectious Diseases for Cherokee Nation Health Service, the largest tribally operated health care system in the United States. He oversees surveillance, policies, and programs to treat and prevent the transmission of COVID-19, sexually transmitted diseases, HIV and HCV.

Whitney Essex, MSN, FNP-BC, is a Family Nurse Practitioner for Cherokee Nation Health Services. Mrs. Essex works in the Infectious Diseases Department, where she is the coordinator for the Cherokee Nation Hepatitis C Elimination program. She assists in the maintenance of general infectious diseases clinical services, as well as the provision of medical care for patients accessing HIV, PrEP, Hepatitis C, and other infectious diseases-related services.

Presentation Slides

What Does a Phase III Vaccine Trial Mean

Clinical Updates

Resources